- Home
- DFIN vs ATRC Comparison
DFIN vs ATRC Comparison
Compare DFIN & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DFIN
- ATRC
- Stock Information
- Founded
- DFIN 1983
- ATRC 2000
- Country
- DFIN United States
- ATRC United States
- Employees
- DFIN N/A
- ATRC N/A
- Industry
- DFIN Other Consumer Services
- ATRC Medical/Dental Instruments
- Sector
- DFIN Consumer Discretionary
- ATRC Health Care
- Exchange
- DFIN Nasdaq
- ATRC Nasdaq
- Market Cap
- DFIN 1.8B
- ATRC 1.6B
- IPO Year
- DFIN N/A
- ATRC 2005
- Fundamental
- Price
- DFIN $54.25
- ATRC $35.45
- Analyst Decision
- DFIN Strong Buy
- ATRC Strong Buy
- Analyst Count
- DFIN 3
- ATRC 10
- Target Price
- DFIN $68.67
- ATRC $49.60
- AVG Volume (30 Days)
- DFIN 312.6K
- ATRC 725.8K
- Earning Date
- DFIN 07-31-2025
- ATRC 07-29-2025
- Dividend Yield
- DFIN N/A
- ATRC N/A
- EPS Growth
- DFIN N/A
- ATRC N/A
- EPS
- DFIN 2.79
- ATRC N/A
- Revenue
- DFIN $755,000,000.00
- ATRC $499,946,000.00
- Revenue This Year
- DFIN $1.91
- ATRC $14.63
- Revenue Next Year
- DFIN $4.64
- ATRC $12.62
- P/E Ratio
- DFIN $19.89
- ATRC N/A
- Revenue Growth
- DFIN N/A
- ATRC 16.28
- 52 Week Low
- DFIN $37.80
- ATRC $22.81
- 52 Week High
- DFIN $70.55
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- DFIN 42.43
- ATRC 56.46
- Support Level
- DFIN $51.18
- ATRC $34.91
- Resistance Level
- DFIN $58.45
- ATRC $36.96
- Average True Range (ATR)
- DFIN 2.61
- ATRC 1.61
- MACD
- DFIN -0.04
- ATRC 0.07
- Stochastic Oscillator
- DFIN 26.94
- ATRC 59.45
About DFIN Donnelley Financial Solutions Inc.
Donnelley Financial Solutions Inc is a risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( USA), Europe, Asia, Canada, and others, of which the USA accounts for the vast majority of its total revenue.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.